Abstract: Malaria is a serious infectious disease that causes over one million deaths yearly. It is caused by a group of protozoan parasites in the genus Plasmodium. No effective vaccine is currently available and the elevated levels of resistance to drugs in use underscore the pressing need for novel antimalarial targets. In this review, we survey omics centered developments in Plasmodium biology, which have set the stage for a quantum leap in our understanding of the fundamental processes of the parasite life cycle and mechanisms of drug resistance and immune evasion.
INTRODUCTION
Malaria is a serious global infectious disease, responsible for over one million deaths yearly. It is caused by the protozoan parasites in the Plasmodium genus. Five species, P. falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi are human pathogens. The most severe form of malaria is caused by P. falciparum.
The life cycle of malaria parasites is complex, including multiple stages spanning the mosquito vector Anopheles and the human host. Infection begins when an infected female mosquito bites a host, injecting the parasites in the form of sporozoites into the bloodstream. The sporozoites enter the human liver in which they undergo asexual multiplication without any clinical symptoms. At the end of the liver stage, the parasites are released in the form of merozoites, which then invade red blood cells (RBCs, erythrocytes). During the RBC cycle, the parasites develop from small rings to metabolically active trophozoites and mature into schizonts, which later rupture and release merozoites. The RBC stage is responsible for the pathology associated with malaria, including recurring fever due to the lysis of the infected erythrocytes. Some merozoites develop into sexually differentiated gametocytes, which can develop into mature gametes when ingested by a mosquito. The gametes are fertilized to form zygotes which develop into ookinetes that penetrate the mosquito's midgut wall and form oocysts on the exterior surface. Inside the oocyst, thousands of active sporozoites develop and migrate to the mosquito's salivary glands, completing the life cycle.
Malaria is an old disease and it is striking back in recent years as parasites have developed increasing resistance to available antimalarial drugs. The completion of genome sequencing of various Plasmodium strains and the rapid development of transcriptomic, proteomic, metabolomic, and interactomic technologies have brought new hope to the development of more effective preventive and therapeutic strategies. This review is focused on recent advances in comparative genomics and systems biology of malaria parasites, which promise to make profound contributions to our understanding of pathogenesis, drug resistance, parasite biology and evolution.
GENOMICS OF PLASMODIUM
The genome of P. falciparum, the most deadly human parasite, was completed and published in 2002 [1] . The partial sequence and contig information of P. yoelii yoelii, a rodent malaria parasite, were published at the same time [2] . Genome sequence data from nine Plasmodium strains are in various stages of completion and are available to the research community in PlasmoDB [3] , a comprehensive genomic resource for malaria parasite research [1, 2, [4] [5] [6] (Table 1) . With the advent of next-generation sequencing technology, the number of completed and ongoing sequencing projects is rapidly increasing. According to an updated version of the comprehensive sequencing proposal for Plasmodium (http://www.genome.gov/Pages/Research/DER/Pathogensan dVectors/PlasmodiumWhitePaperV8.pdf), as of March 21, 2011 , US National Institute of Allergy and Infectious Diseases (NIAID) has approved the sequencing of 105 malaria parasite strains/isolates from a wide variety of geographical regions, including 75 P. falciparum isolates, nine isolates of P. vivax, the second most important human malaria parasite, representative simian malaria parasites (P. reichenowi, P. cynomolgi, P. inui, P. coatneyi, P. fragile), rodent parasites (P.chabaudi, P. yoelii, and P. berghei), avian parasite P. relictum, and a reptile parasite P. mexicanum.
The haploid Plasmodium genome is organized into 14 linear chromosomes, encoding about 5,100-5,800 open reading frames (ORFs) ( Table 1 ). The genome size typically ranges from 16-26 Mb. The (A+T) content varies significantly among Plasmodium species: on average, 80.4% of the P. falciparum genome consists of A or T, and this proportion can be as high as 90% in introns and intergenic regions, while the P. vivax genome contains only 57.5% (A+T). The A+T richness presents multiple challenges in functional genomics of P. falciparum: low-complexity regions (LCRs) are dispersed all over the genome, which hampers accurate genome annotation, and over 60% of the ORFs were annotated as hypothetical proteins due to the lack of statistically significant sequence similarity to any known or characterized proteins; strong AT bias makes cloning in heterogeneous vector systems such as E.coli and yeast difficult [7] ; it is difficult to design standard probes for quantifying mRNA expressions [8] ; the vector for high throughput yeast two-hybrid (Y2H) assays for screening protein-protein interactions had to be modified to achieve a low false-positive detection rate [9] . Nevertheless, deciphering the parasite genomes has provided invaluable insights into various aspects of parasite biology, related to genetic diversity, parasite transmission, invasion, growth, development, response to drug administration and pathogenesis.
The Core Genome and Lineage-Specific Features of the Malaria Parasites
Malaria parasites are rapidly evolving pathogens under constant endogenous and exogenous selection pressure from the host, the vector, and the environment. Phylogenetic analysis based on mitochondrial genome sequences reveals strong correlation between the parasites and their host ranges, suggesting a pathogen-host coevolution scenario (Fig. 1A) [10] . The avian and reptile parasites show close kinship, and rodent parasites are clustered into one single group. The human and nonhuman primate malaria parasites form two clades: P. falciparum and the chimpanzee parasite P. reichenowi are sister taxa, while divergent from other primate parasites. The origin of P. falciparum remains controversial: historically, it was thought to be derived from a bird/reptile parasite [11] and a big-bang mode of radiation; this hypothesis has recently been challenged by several independent lines of evidence showing that host switches occurred in multiple human and nonhuman primate parasites: P. knowlesi, whose natural host was thought to be macaques, indeed is a widely distributed human parasite [12] , and similarly African apes have been shown to be natural hosts for P. falciparum [13] [14] [15] [16] [17] [18] . Combining single genome amplification polymerase chain reaction (PCR) technique and sequence analyses of mitochondrial, apicoplast, and nuclear genes, Liu et al. (2010) suggested that P. falciparum originated from a single gorilla-to-human transmission [19] . Prugnolle et al. in a series of studies showed that P. falciparum can circulate in great apes and monkeys, and is not confined to gorillas [17, 18, 20] . Similarly, recent host transfers seem to have occurred among other human malaria parasites including P. vivax and P. malariae and monkey parasites P. simium and P. brasilianum. The host switching phenomena have been well defined and studied in viruses such as influenza A [21, 22] . The possibility of malaria parasites switching hosts could have profound impacts on the parasite evolution as new strains might be derived from host shift, representing new risks for human public health.
Consistent with the patterns revealed by phylogenetic analysis, genome alignment shows that the five genomes with completed sequences belong to three distinct groups (Fig. 1B) , Two rodent parasites, P. chabaudi chabaudi and P. berghei, are closely related to each other, with an average of 87% of nucleotide sequence similarity [5] and conserved chromosome synteny. P. vivax and P. knowlesi share conserved chromosome organization, while P. falciparum seems to have undergone significant chromosomal rearrangements.
Despite the diverse physiological and ecological niches of the malaria parasites, their genomes share common conserved features. Comparative genomic analysis of six genomes with complete annotations (P. falciparum, P. vivax, P. chabaudi chabaudi, P. berghei, P. yoelii yoelii and P. knowlesi) revealed that the core genome is comprised of [23] . In addition to the genes required for fundamental biology, the core genome contains components important for parasite-specific lifestyles. These include: (1) 15 orthologous clusters including various kinases and transcription factors involved in the cell cycle network; (2) At least one cluster that may participate in a G-protein coupled receptor (GPCR) signaling pathway. It was shown that signaling via human GPCR regulates parasite entry to the RBC and parasite infection is blocked by a GPCR inhibitor [24] , suggesting that GPCR agonists can be potential drug targets; (3) 23 clusters related to parasite stress response; (4) six clusters relevant to pathogenesis or virulence, including the clusters encoding merozoite surface proteins (MSPs) [25] , transmission-blocking target antigens [26] , chloroquine resistance transporters and multidrug resistance proteins. These core components represent the minimum requirement for a successful life cycle that spans vertebrate hosts and mosquito vectors. Much of our current knowledge in parasite biology has been derived from studies conducted in non-human parasites, due to the restricted host specificity of human parasites. There are multiple advantages to using non-human parasites: the liver and mosquito stages of the human parasites are difficult to study, while large scale in vitro cultivation and production of these stages for rodent parasites are well developed; it is feasible to study parasite-host interactions in vivo with rodent parasites as well as in vivo drug testing; gene knockouts in rodent hosts are useful to study protective immunity or immunopathology. Comparative genomic analysis confirms the conservation of the housekeeping genes, drug resistance genes, and surface antigens between the rodent and human parasites, suggesting that reasonable extrapolations from animal models can provide invaluable insights into the mechanisms of human malaria.
Comparative genomic analysis has also identified abundant lineage-specific expansions (LSEs), constituting about 5-9% of the genomes. The majority of the LSE families are hypothetical proteins with unknown functions. For example, 77% of the gene families that are expanded uniquely in P. berghei were hypothetical or putative proteins. Some of the LSEs encode surface antigens. In P. falciparum, the largest cluster is the RIFIN family with 165 paralogous members. Multiple gene duplications, followed by neo-functionalization and subfunctionalization, may give rise to the current distribution of the RIFIN family [27] ; the antigenic variation observed in this enigmatic family suggests that it plays a role in cytoadherence and can serve as a vaccine target. The second largest LSE in P. falciparum, erythrocyte membrane protein 1 (PfEMP1), is also notorious for antigenic variation [28, 29] . Although antigenic variation is common in Plasmodium species as a mechanism for parasite evasion of the host immune response, different parasites may evolve lineage-specific surface antigens with tissue-specific activities. Vir genes, coding for variant antigens exposed on P. vivax-infected reticulocytes, are associated with spleen-specific cytoadherence in chronic infections [30, 31] . SICAvar-like antigens, the simian specific surface antigens, are present in P. knowlesi, and are implicated in parasite virulence [6] .
Fig. (1). (A)
A phylogenetic tree of Plasmodium parasites. The tree was inferred from partial mitochondrial genomes using the neighborjoining method based on the nucleotide sequences with Kimura 2-parameter distance [199] . Evolutionary analyses were conducted in MEGA5 [200] . The option of complete deletion of gaps was used for tree construction. 1,000 bootstrap replicates were used to infer the reliability of branching points. Bootstrap values of >50% are presented. The Leucocytozoon sabrazesi mitochondrial sequence was set as the outgroup. : P. falciparum and P. reichenowi; : rodent parasites; : other primate parasites; : avian and reptile parasites. The Maximum Parsimony and Maximum Likelihood methods give virtually the same topology (data not shown). (B) Genome alignment of five Plasmodium genomes, using MAUVE 2.3.1 [201] . The 14 chromosome regions are marked with arrows. Comparative genomics, in addition to its contribution to a better understanding of parasite evolution, offers a cost effective means to search for potential antimalarial targets in silico. Comparative analyses of evolutionarily related genes, gene products, structures, pathways, and networks have already lead to the discovery of potential drug targets, including (1) multiple enzymes such as 1-deoxy-D-xylulose 5-phosphate (DOXP) reductoisomerase [32, 33] , andapicoplast gyrase [34] that are essential for the replication, transcription, translation, and metabolism of the apicoplast. The apicoplast is an organelle that is required for parasite life cycle, as parasites are not viable when the metabolism and replication of apicoplast is inhibited [35, 36] . The proteins targeted to the apicoplast are considered to be attractive targets because this organelle is of prokaryotic origin and is distantly related to the human host; (2) kinases such as cyclin-dependent protein kinases (Pfmrk) [37] , which may play an important role in DNA replication, transcription, and cell cycle regulation, and the plant-like calcium-dependent protein kinase (PfCDPK5) [38] , which regulate the parasite exit from the RBCs; (3) transporters, which have demonstrated importance in drug resistance and nutrient acquisition from the host [39] [40] [41] [42] [43] [44] .
Data mining approaches combining traditional sequence similarity search, structural genomics, and machine learning techniques also identified a catalog of proteases that play versatile roles in parasite biology [45] [46] [47] , including a series of aspartic proteases (plasmepsins) [48, 49] , papain-type cysteine proteases (falcipains) [50, 51] , and metallo aminopeptidases [52] [53] [54] that catalyze a cascade of reactions to digest host hemoglobins to liberate free amino acids for parasite nutrition, metacaspases that are potential mediators for programmed cell death-like pathways [55] [56] [57] , a calpain that is crucial for parasite optimal growth and cell cycle progression [58] , serine proteases (subtilases) that are essential for parasite invasion as well as egress from the erythrocytes [59] [60] [61] , and several families of proteases involved in heat shock response and stress response [62, 63] . In addition, three classes of proteases have been discovered in P. falciparum that mediate regulated intramembrane proteolysis (RIP), including an aspartic signal peptide peptidase (PfAPP) in the A22 presenilin family, two Site-2 metallo proteases (S2Ps) in the M50 family [64] , and eight rhomboid serine proteases (PfROMs) in the S54 family [65] [66] [67] [68] [69] [70] [71] . RIP is a novel signaling mechanism, in which proteases process the transmembrane segments of the substrates, releasing cytosolic fragments that control the transcription of their effector proteins, thereby regulating cellular processes such as differentiation, metabolism, and protein turnovers [72] . Proteases are proven central players in RIP in bacterial, fungal, viral, and protozoan pathogens, and are emerging classes of therapeutic targets [73] . In P. falciparum, PfAPP has been implicated in meroziote invasion and parasite growth [69, 70] . Various PfROMs showed differential cleavage preference to an array of adhesins including the apical membrane antigen 1 (AMA1), the erythrocyte binding-like (EBL) family, the reticulocyte binding-like (RBL) family, and the thrombospondin-related anonymous protein (TRAP) family, suggesting that the parasite rhomboid proteases are involved in invasion [65] . The potentials of malarial proteases as drug targets have been evaluated via structural modeling, rational inhibitor design, and combinational compound screening [53, [74] [75] [76] [77] [78] [79] [80] [81] . Many of these drug targets have no human homologs or have only a distant evolutionary relatedness to their counterparts in the humans; the drugs targeting to these candidate proteins therefore may have no or little side effects on the human system.
The search for potential drug targets in the superfamily of transcription factors, however, has been hindered by the remote homology between the transcriptional machinery in P. falciparum and that in other well-studied model organisms [82] . Combining hidden Markov model (HMM)-based domain search, secondary structural prediction, 3D structural homology modeling, phylogenetic analysis, and microarray transcriptomic data mining, Balaji et al. [83] discovered a novel family of transcriptional regulators, namely apicomplexan Ap2 (ApiAP2) family in P. falciparum and two other related apicomplexan parasites. This is the first and sole non-basal transcription factor (TF) family that has been identified in Plasmodium. ApiAP2 proteins contain the Apetala2 (AP2) domains that are commonly presented in plants, which are the key regulators for the ABC model of flower development [84] . It was postulated that the ApiAP2 proteins were acquired from the apicoplast progenitor or bacteria via transposition, followed by lineage-specific expansion [83] . Malaria parasites have 26-28 ApiAP2 members, with similar conserved domain architecture across different Plasmodium species. Unlike the plant ApiAP2 family which typically has one or two AP2 domains, four ApiAP2 proteins (PFF0670w, PF10_0075, PF11_0404, and PF13_0235) in P. falciparum have three AP2 domains. The roles of ApiAP2 proteins in parasite developmental control have been unraveled by functional genomic and transcriptomic analyses and gene knockout assays (See Painter et al. [85] for an excellent review). They have been implicated in transcriptional regulation throughout the life cycle, influencing parasite invasion, gametogenesis, oocyst developmentm sporozoite development, and gene silencing [86] [87] [88] [89] [90] [91] , opening a new line of targets for functional characterization.
Comparative genomics has been invaluable to malaria vaccine development in pinpointing potential antigens. Prior to the completion of genome sequencing, only about 30 antigens were being used as vaccine targets. Genome annotation predicted three large supergene families var, rif, and stevor, which code for PfEMP1, repetitive interspersed family (RIFIN) and sub-telomeric variable open reading frame (STEVOR), and a plethora of potential antigens that may contribute to parasite immune evasion [1] . For example, a series of transmission blocking vaccine (TBV) candidates are currently at various stage of experimental assessment and some of them are under pre-clinical trials, including Pfs25/Pvs25 [92] , Pfs28/Pvs28 [93] , Pfs48/45 [94] , and Pfs230 [95, 96] . The TBVs target the sexual or mosquito stage of the parasite and prevent the parasite transmission. New computational methods and wet-lab genome-wide screening have been used to identify novel vaccine candidates with distinct structure motifs [97] [98] [99] [100] [101] . Although high level of polymorphism and genetic diversity remain a major hurdle for malaria vaccine development [102] , the availability of genome information provides a foundation for genome-wide scan and evaluation of vaccine targets.
THE POST-GENOMIC ERA
The malaria research community is rapidly advancing upon the post-genomic era. High throughput technologies such as microarray DNA chip, mass-spectrometry, and yeast two-hybrid (Y2H) screening have enabled the rapid and large-scale characterization and profiling of the expression, regulation and interaction of the genes at the level of the transcriptome, proteome, metabolome, and interactome [103] .
The application of microarray chips dates back to the beginning of millennium, even before the completion of the genome sequencing of P. falciparum. The first generation of microarray chips include shotgun genomic microarrays [104] and stage-specific cDNA microarrays [105] . Oligonucleotide arrays were custom designed and fabricated for P. falciparum, including an ORF-based array of long 70-mer oligonucleotides [106, 107] and short 25-mer oligonucletide arrays [108, 109] . A groundbreaking work by Bozdech et al. [106] revealed, for the first time, that the transcription of genes in the blood stage in malaria parasite uses a "just-intime" mechanism, i.e., genes are expressed only when they are required. At different stages in the RBC cycle, specific sets of genes are orchestrated to fulfill special needs for parasite development and infection. For example, the ring and early-trophozoite stage is characterized by the induction of genes important for transcription, translation, and fundamental metabolism such as glycolysis, while the schizont stage is characterized by the expression of genes associated with merozoite invasion and immune evasion. This study has also made an enormous impact on the bioinformatics community as it was used as a contest dataset in the 2004 Critical Assessment of Microarray Data Analysis (CAMDA) conference, which boosted the development of novel computational algorithms for microarray analysis. Many of these methods have been extended to systems-wide studies of other organisms or cellular systems. Another microarray study [109] that has significant impacts on malaria research focused on the temporal profiling of the entire life cycle of the parasite, spanning the blood stage, the gametocyte and the sporozoite stages. Many genes that were co-expressed seemed to be associated with correlated cellular processes such as cell cycle regulation, transport and trafficking, defense and virulence, cell-cell communication and signal transduction, suggesting the parasite uses a very efficient cellular machinery [106, 109] . The microarray chips for other Plasmodium species/strains, including P. berghei [5] , P. yoelii [110, 111] , P. vivax [112] have also been developed. Transcriptomic profiling is becoming one of the most powerful means of elucidating complex mechanisms that were previously impossible or difficult to study [113] , including the mechanisms of cell cycle regulation [114] , transcriptional control under various conditions [5, [115] [116] [117] [118] [119] [120] , gene silencing [121] , genetic diversity, drug action and drug resistance [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] , parasite invasion [134] , pathogenesis and virulence [135] [136] [137] [138] [139] [140] [141] [142] , vector-parasite and host-parasite interactions [140, 143, 144] , and sexual development [145] . The results have lead to the identification of novel drug and vaccine targets [47, [146] [147] [148] [149] [150] [151] . ChIP (chromatin immunoprecipitation)-on-chip technology has been used to identify and characterize the cistrome, the whole complement of DNA-binding sites for target proteins, and to study the mechanisms of epigenetic modeling and programming [116, 119, [152] [153] [154] [155] . RNA-Seq, which applies next-generation sequencing (NGS) technologies to the highresolution sequencing of expressed RNA transcripts, has been successfully used in the human [156, 157] , yeast [158, 159] , and mouse systems [160] . The first RNA-Seq analysis in P. falciparum was published in 2010. It made corrections to existing gene models, predicted rare temporal-specific alternative splicing events, identified novel transcripts and low abundance transcripts, and provided a blueprint of the transcriptomes at seven time points during the blood stage [89] . Although still in its infancy, RNA-Seq offers promises to achieve a fast, accurate, and comprehensive view of the parasite transcriptional and post-transcriptional regulation. Recently, Vignali et al. [161] design not-so-random (NSR) primers using a novel next-generation sequencing (NGS) technology, namely NSR-Seq [162] , to profile the nonribosomal RNA transcripts in P. falciparum; they reported a signature profile of genes for parasites infecting children, demonstrating the value of NSR-Seq for the characterization of clinical samples.
Complementary to transcriptomic analysis, proteomics enables researchers to study the expression, function, and structure of proteins at a large scale. Typically, proteomic studies involve three steps: (1) sample isolation; (2) protein separation, for example, by two-dimensional (2-D) gel electrophoresis; (3) quantitative identification and analysis of the individual proteins by mass spectrometry or N-terminal sequencing. Systems-wide analyses of proteomes are possible due to the advent of high throughput technologies such as matrix-assisted laser desorption ionization-time-offlight (MALDI-TOF) mass spectrometry, capillary liquid chromatography, followed by tandem mass spectrometry (LC-MS/MS), and Multidimensional Protein Identification Technology (MudPIT) which couples liquid chromatography and tandem mass spectrometry. The proteomes of the P. falciparum asexual trophozoites and schizonts, sexual stage gametocytes, and gametes were revealed by a high accuracy LC-MS/MS analysis [163] , and the proteomes of the sporozoite, merozoite, trophozoite and gametocyte stages were elucidated using MudPIT [164] . Potential drug targets, such as proteases and transporters, as well as vaccine targets were found to be expressed at specific stages and subcellular locations in multiple Plasmodium strains [46, 47, 110, [165] [166] [167] [168] [169] . MudPIT also enabled the identification of surface antigens and epitopes expressed in the sporozoite and intrahepatic stages [170] and proteins on the surface of parasite-infected erythrocytes (PIESPs), which may play a role in pathogenesis and immunity [171] . LC-MS/MS identified several PfEMP1 variants in membrane proteinenriched P. falciparum-infected erythrocytes in laboratory isolates, field isolates and fresh placental parasite preparations, suggesting PfEMP1 may be associated with parasite adhesion in placental malaria [172] . It also identified glycosylphosphatidylinositol (GPI) -anchored membrane proteins which play diverse roles in parasite growth and invasion [173] . A quantitative proteomic method based on SILAC (stable isotope labeling by amino acids in cell culture) technology was developed to monitor protein expression and post-translationally modified variants in the blood stage and in the parasite responses to antimalarial drugs [174] . Proteomics has shed light on the mechanisms of parasite invasion and pathogenesis: MudPIT identified proteins that are localized to rhoptries, specialized secretory organelles, which are uniquely present within Apicomplexa parasites including Plasmodium, and are important for rupture, invasion, and RBC remodeling [175] . This technology also identified a group of membrane proteins in the Maurer's clefts (MCs), parasite-specific structures that are associated with parasite transport and secretion pathways [176] . Comparative LC-MS/MS proteomics between P. falciparum and P. berghei identified previously uncharacterized proteins that are essential for parasite growth and maturation in the mosquitoes [177] . The proteome of micronemes, Apicomplexan-specific secretory organelles that are important for gliding motility and host cell invasion, purified from the cultured ookinete, was recently published [178] , revealing novel proteins that are related to vesicle trafficking and signaling functions for effective invasion. Proteomics offers a systematic way to characterize drug actions and drug resistance: 2-D gel electrophoresis and MALDI-TOF MS revealed the complex pharmacological effects of an antimalarial CoArtem, artemether and lumefantrine [179] ; MudPIT analysis revealed expression changes in the trophozoites under chloroquine and artemisinin pressure [180] . Surface-enhanced laser desorption/ionization (SELDI)-TOF-MS was developed to compare the global protein expression profiles between drug resistant and sensitive parasite strains, leading to the identification of molecular markers for drug susceptibility and action [181] .
Metabolomics in malaria biology is aimed at the elucidation of the metabolism of Plasmodium. The approaches range from in silico inferences, as seen in PlasmoCyc, a pathway genome database (PGDB) for P. falciparum [182] , the Malaria Parasite Metabolic Pathways (MPMP) database [183] , and flux-balance analysis (FBA) [184] , to wet-lab extraction and separation of metabolites and metabolic profiling using nuclear magnetic resonance (NMR) or MS (see [185] for a comprehensive review). The networks for lipid, polyamine, glycerol and carbon metabolism have been unveiled and novel enzymatic drug targets identified, enhancing our understanding of the biochemical environments in the host and vector, and of host-parasite/vector-parasite interactions [36, [186] [187] [188] [189] .
Interactomics provides a network view of the proteinprotein interactions (PPI) and other interactions within a cell. Yeast two-hybrid (Y2H) screening identified 2,846 unique PPIs in P. falciparum, that may play roles in transcriptional regulation, chromatin modification, mRNA stability, parasite invasion [9] . Subsequent analysis [190] identified almost 3,000 interactions among about 1,300 (mostly 'hypothetical' proteins). They fell into 29 complexes, but the relatively small numbers of proteins with informative functional annotations impaired a detailed analysis of the interaction networks. Alternatively, the P. falciparum interactome was inferred by integrating functional genomic data in a Bayesian statistical framework [191] . Interactomic studies, which actually integrate the individual components of the malaria parasite into an overview of whole-organism interactions, represent a first step into the nascent field of systems biology.
Toward a Systems Level Understanding of Parasite Biology
A growing body of evidence suggests that adaptive properties of malaria parasites, such as stress response, drug resistance, host entry, and pathogenesis, are complex traits involving associations among proteins, metabolites, DNAs, RNAs and other molecules in the cell. Systems biology approaches to the study of the malaria parasite began to appear shortly after the completion of the genome sequencing. Many of the studies cited above can be viewed as systems biology approaches in that a common goal is the synthesis of a high-level view of the malaria parasite. Isokpehi and Hide [151] used integrative data analysis to identify a set of proteins that showed stage-specific expression and discussed the possible importance of the gene products in parasite biology and as potential drug targets. Yeh et al. [182] searched for what they called "chokepoint" enzymes in P. falciparum by analyzing the interactions among proteins that had been mapped into metabolic pathways using the Pathway Tools software. Ralph et al. [36] used a comparative genomics approach to identify apicoplast-targeted proteins and were able to reconstruct apicoplast metabolic networks. Other studies, like the Y2H systems [9, 190] , transcriptomic analysis ( [88] , for example) and computational deduction of the interactome [191] all attempt to place our knowledge of the gene (or protein) complement and its expression into a larger unified framework. These studies are significant milestones on the road to a true systems view of the parasite. Clearly, the field of systems biology is forging ahead, but just as clearly, computational methods for integrating data and inferring networks are needed [192] [193] [194] [195] [196] . It is worth emphasizing that the insights provided by omics approaches into the dynamics of biological networks will shed light on as yet unrecognized network interactions, thus providing a form of annotation feedback to the determination of system structure. A systems understanding of the Plasmodium parasites will result in a major step forward in the battle against malaria [197, 198] . 
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